These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1440407)

  • 41. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerance to the hemodynamic and antianginal effects of the organic nitrates.
    Parker JO
    Z Kardiol; 1985; 74 Suppl 1():45-9. PubMed ID: 3922142
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of the effect of a new anti-anginal drug, isosorbide dinitrate tape (TY0081), by Holter electrocardiography].
    Kohya T; Itoh K; Ando J; Tomita K; Yasuda H
    Kokyu To Junkan; 1983 Feb; 31(2):181-7. PubMed ID: 6867483
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nitrates in therapy of effort angina in hypotensive patients].
    Idrisova EM; Borovkova NV; Kladieva EA; Chernov VI; Demochko AV; Shishkina AA; Vorob'eva EV; Karpov RS
    Klin Med (Mosk); 2003; 81(11):54-8. PubMed ID: 14689713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of sustained-action isosorbide dinitrate on exercise-induced myocardial ischemia.
    Brunner D; Meshulam N; Zerieker F
    Chest; 1974 Sep; 66(3):282-7. PubMed ID: 4607776
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparison of 2 recent isosorbide dinitrate preparations as new long-term galenicals with commonly used delayed-action preparations].
    Hagel H
    ZFA (Stuttgart); 1984 Jan; 60(1):40-3. PubMed ID: 6711082
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect of nitrosorbide, korinfar, obzidan and spesikor on cardiovascular function in a right bundle of His block].
    Vorob'ev LP; Maev IV; V'iuchnova ES
    Ter Arkh; 1992; 64(12):83-7. PubMed ID: 1292142
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cooperative study on the long-term use of anti-anginal preparations (methodologic questions)].
    Metelitsa VI; Kokurina EV; Piotrovskiĭ VK; Martsevich SIu; Riabokon' OS
    Kardiologiia; 1985 Sep; 25(9):67-72. PubMed ID: 4079229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
    Zharov EI; Sal'nikov SN; Vertkin AL
    Kardiologiia; 1987 Feb; 27(2):41-6. PubMed ID: 3106696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacodynamics of a nitroglycerin ointment in patients with stenocardia of effort].
    Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
    Kardiologiia; 1985 Apr; 25(4):41-4. PubMed ID: 3927053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of isosorbide dinitrate of prolonged action on the prevention of myocardial ischemia induced by exercise: correlation with nitrate blood levels].
    Duprat R; Meneghelo RS; Batlouni M; Hoxter G
    Arq Bras Cardiol; 1975 Jun; 28(3):369-77. PubMed ID: 1180718
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pectanginose boring arrested by inhalation of isosorbide dinitrate (author's transl)].
    Bräuer R; Otto C
    Schweiz Rundsch Med Prax; 1979 Jan; 68(4):117-23. PubMed ID: 760114
    [No Abstract]   [Full Text] [Related]  

  • 54. [The antianginal efficacy of verapamil and nitrosorbide used separately and jointly in patients with angina of effort].
    Kostko SZ; Zhiberina LA; Mukhitdinova GN
    Kardiologiia; 1993; 33(10):22-3. PubMed ID: 8139165
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of drug effects by exercise electrocardiograms].
    Kimura E; Mabuchi G
    Nihon Rinsho; 1972 Aug; 30(8):1739-45. PubMed ID: 4561814
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of transesophageal electrostimulation of the heart for evaluating the effectiveness of anti-anginal therapy].
    Makolkin VI; Petriĭ VV
    Kardiologiia; 1987 Apr; 27(4):22-5. PubMed ID: 3599628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An evaluation of the role of paired loading tests in selecting the long-term drug therapy for patients with stable angina].
    Voronkov LG; Sokolov NF; Sharaeva ML; Kuts' VA; Lomakovskiĭ AN
    Kardiologiia; 1993; 33(10):12-5, 3. PubMed ID: 8139163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Antiangina or antimyocaridal ischemia drugs.
    Kattus AA
    Chest; 1975 Jun; 67(6):632-3. PubMed ID: 805036
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlation of the anti-angina effect of nitrosorbide in patients with stenocardia of effort following a single dose and a course of treatment].
    Arifdzhanova UA; Kostko SZ; Vakhidova MA; Trigulova RKh; Kasymkhodzhaev ASh
    Kardiologiia; 1987 Dec; 27(12):93-4. PubMed ID: 3444227
    [No Abstract]   [Full Text] [Related]  

  • 60. [A comparative evaluation of the antianginal action of commercially and noncommercially produced validol in neurocirculatory dystonia and stenocardia].
    Bondarenko IP; Liashenko MM; Chirkov SN; Ermakovich II
    Lik Sprava; 1996; (3-4):110-3. PubMed ID: 9035841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.